OTC & Nutraceuticals Europe

Europe Elderly Nutrition Products Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Europe Elderly Nutrition Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $5.15 Bn Placeholder estimate
Estimate 2025 $5.41 Bn 19.3% of the global market
Projected 2034 $8.46 Bn 56.5% Adds $3.05 Bn over 9 forecast years
CAGR 2025–2034 5.1% Faster than 31% of 83 OTC & Nutraceuticals markets here
Key players 5
  • Europe is 19.25% of the global market.
  • Among regions, the largest is North America at $14.14 Bn.
  • Fastest growing: APAC at 7.6% a year.
  • Europe ranks 2nd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$3.05 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Elderly Nutrition Products Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $5.15 Bn — —
2025 (base) $5.41 Bn +$262.4 Mn —
2026 (forecast) $5.68 Bn +$275.8 Mn +5.1%
2027 (forecast) $5.97 Bn +$289.9 Mn +10.5%
2028 (forecast) $6.28 Bn +$304.7 Mn +16.1%
2029 (forecast) $6.60 Bn +$320.2 Mn +22%
2030 (forecast) $6.94 Bn +$336.5 Mn +28.2%
2031 (forecast) $7.29 Bn +$353.7 Mn +34.8%
2032 (forecast) $7.66 Bn +$371.7 Mn +41.7%
2033 (forecast) $8.05 Bn +$390.7 Mn +48.9%
2034 (forecast) $8.46 Bn +$410.6 Mn +56.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Elderly Nutrition Products Market Analysis at a glance
Market size, 2025$5.41 Bn placeholder estimate
Forecast, 2034$8.46 Bn placeholder estimate
Growth (CAGR), 2025–20345.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and distribution channel (see all)
Key playersAbbott Laboratories, Nestle, Danone Nutricia, Fresenius Kabi AG, Ajinomoto Co (see all)
Regulator in EuropeEMA and EFSASource: European Medicines Agency. Checked 14 Nov 2026.Source: European Food Safety Authority. Checked 14 Nov 2026.
Active clinical trials34 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Elderly Nutrition Products Market Analysis Executive Summary

Elderly nutrition products are foods and drinks designed for older adults, such as high-protein shakes, texture-modified meals and oral supplements.

Key segments of the elderly Nutrition Products market include product (Oral Nutritional Supplements, Texture-Modified Foods and Protein Fortified Foods) and setting (Home, Hospitals and Care Homes).

Bar chart: Europe Elderly Nutrition Products market size, 2024–2034, placeholder estimates. $5.15 Bn in 2024, $5.41 Bn in 2025 and $8.46 Bn in 2034, 5.1% CAGR.
Europe Elderly Nutrition Products market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Elderly Nutrition Products Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the elderly Nutrition Products market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the elderly Nutrition Products market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the elderly Nutrition Products market.

Competitive Landscape for Elderly Nutrition Products Market in Europe

The elderly Nutrition Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Elderly Nutrition Products Market in Europe

Elderly Nutrition Products in Europe: rules and research

In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA).⁠[1] In the countries we cover here, medicines are approved by ANSM (France)⁠[2], BfArM (Germany)⁠[3], AIFA (Italy)⁠[4], Ministry of Health (Russia)⁠[5], AEMPS (Spain)⁠[6], MHRA (UK)⁠[7], CBG-MEB (Netherlands)⁠[8], FAMHP (Belgium)⁠[9], Swissmedic (Switzerland)⁠[10], Läkemedelsverket (Sweden)⁠[11], Danish Medicines Agency (Denmark)⁠[12], URPL (Poland)⁠[13] and TITCK (Turkey)⁠[14]. EU law sets common rules for food supplements, and the European Food Safety Authority (EFSA) assesses their health claims.⁠[15] In the countries we cover here, supplement rules come from DGCCRF and ANSES (France)⁠[16], BVL (Germany)⁠[17], Ministry of Health (Italy)⁠[18], Rospotrebnadzor (Russia)⁠[19], AESAN (Spain)⁠[20], FSA (UK)⁠[21], NVWA (Netherlands)⁠[22], FPS Public Health (Belgium)⁠[23], FSVO (Switzerland)⁠[24], Livsmedelsverket (Sweden)⁠[25], Danish Veterinary and Food Administration (Denmark)⁠[26], GIS (Poland)⁠[27] and Ministry of Agriculture and Forestry (Turkey)⁠[28]. ClinicalTrials.gov lists 34 studies on Elderly Nutrition Products that are recruiting, active or about to start in Europe.⁠[29]

[1] European Medicines Agency. Checked 14 Nov 2026.

[2] ANSM, French medicines agency. Checked 14 Nov 2026.

[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.

[4] Italian Medicines Agency (AIFA). Checked 14 Nov 2026.

[5] Ministry of Health of the Russian Federation. Checked 14 Nov 2026.

[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.

[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[8] Medicines Evaluation Board (CBG-MEB). Checked 19 Nov 2026.

[9] Federal Agency for Medicines and Health Products (FAMHP). Checked 19 Nov 2026.

[10] Swissmedic. Checked 19 Nov 2026.

[11] Swedish Medical Products Agency (Läkemedelsverket). Checked 19 Nov 2026.

[12] Danish Medicines Agency. Checked 19 Nov 2026.

[13] Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL). Checked 19 Nov 2026.

[14] Turkish Medicines and Medical Devices Agency (TITCK). Checked 19 Nov 2026.

[15] European Food Safety Authority. Checked 14 Nov 2026.

[16] ANSES. Checked 14 Nov 2026.

[17] Federal Office of Consumer Protection and Food Safety (BVL). Checked 14 Nov 2026.

[18] Italian Ministry of Health. Checked 14 Nov 2026.

[19] Rospotrebnadzor. Checked 14 Nov 2026.

[20] Spanish Agency for Food Safety and Nutrition (AESAN). Checked 14 Nov 2026.

[21] Food Standards Agency. Checked 14 Nov 2026.

[22] Netherlands Food and Consumer Product Safety Authority (NVWA). Checked 19 Nov 2026.

[23] FPS Public Health, Food Chain Safety and Environment. Checked 19 Nov 2026.

[24] Federal Food Safety and Veterinary Office (FSVO). Checked 19 Nov 2026.

[25] Swedish Food Agency (Livsmedelsverket). Checked 19 Nov 2026.

[26] Danish Veterinary and Food Administration. Checked 19 Nov 2026.

[27] Chief Sanitary Inspectorate (GIS). Checked 19 Nov 2026.

[28] Ministry of Agriculture and Forestry. Checked 19 Nov 2026.

[29] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern elderly Nutrition Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Elderly Nutrition Products right now, from free public sources.

Clinical trials

34 active trials in UK, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Denmark, Poland, Turkey and Russia

Recruiting, about to start, or running now. Counted across the 13 countries we report on in Europe.

See every trial on ClinicalTrials.gov (opens in a new tab)

Patients

People aged 65 and over, % of people (World Bank)
CountryValueYear
Belgium21.02025
Denmark21.12025
France22.52025
Germany23.72025
Italy25.12025
Netherlands20.92025
Poland20.82025
Russia17.82025
Spain21.62025
Sweden20.92025
Switzerland20.42025
Turkey10.62025
UK19.72025
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 19 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Elderly Nutrition Products in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Elderly Nutrition Products market in Europe?
Placeholder estimate: about $5.41 Bn in 2025, rising to about $8.46 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Elderly Nutrition Products market in Europe growing?
Placeholder estimate: about 5.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Elderly Nutrition Products market report cover?
The report splits the market by product (Oral Nutritional Supplements, Texture-Modified Foods, Protein Fortified Foods, Thickening Agents), setting (Home, Hospitals, Care Homes) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Elderly Nutrition Products market?
Key players include Abbott Laboratories, Nestle, Danone Nutricia, Fresenius Kabi AG and Ajinomoto Co.
What is driving the Elderly Nutrition Products market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the elderly Nutrition Products market. Older adults and their families are spending more on staying active and independent.
Who regulates Elderly Nutrition Products in Europe?
In the EU, many new medicines are authorised once for every member state by the European Commission, after review by the European Medicines Agency (EMA). EU law sets common rules for food supplements, and the European Food Safety Authority (EFSA) assesses their health claims. Source: European Medicines Agency. Checked 14 Nov 2026. Source: European Food Safety Authority. Checked 14 Nov 2026.
How many clinical trials on Elderly Nutrition Products are running in Europe?
34 studies are recruiting, active or about to start in Europe, counted across the 13 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Elderly Nutrition Products?
PubMed lists 42 papers on Elderly Nutrition Products added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in Europe

See all

Related on geriatric and nutrition

See the topic